Improved culture conditions for clonogenic growth of primary human breast tumours. by Hug, V. et al.
Br. J. Cancer (1984), 50, 207-213
Improved culture conditions for clonogenic growth of
primary human breast tumours
V. Hug, M. Haynes, R. Rashid, G. Spitzer,1 G. Blumenschen & G. Hortobagyi
The University of Texas M. D. Anderson Hospital and Tumor Institute at Houston, Department ofMedical
Oncology and 'Department ofHematology, 6723 Bertner Avenue, Houston, TX 77030, USA
Summary Four established human breast tumour cell lines with different biologic properties were selected
for study and requirements for their clonogenic growth in semisolid cultures were identified. The conventional
conditions were modified by factors that enhanced colony formation of 3 or more of these cell lines. The
modified culture conditions were then applied to the growth in agar of primary breast tumours. A 5-fold
improvement in plating efficiency was observed when cultures of 105 primary tumours grown under these
modified conditions were compared to those of 52 tumours grown earlier under conventional conditions, and
a 4-fold improvement resulted from the addition of hormones and conditioned medidum in 26 tumours
cultured simultaneously under both conditions. The biologic relevance of these clonogens recovered in vitro
was substantiated by a 70% concordance of in vitro and in vivo tumour sensitivity to anticancer drugs.
The clonogenic growth of primary human tumours
is a field of interest for the study of tumour biology
and of inherent tumour sensitivity to anticancer
drugs. Breast tumour cultures are of particular
interest because of the common occurrence of this
tumour and because of its frequent hormone
dependence. However, not all primary breast
tumours form colonies in semisolid cultures, and
the number of colonies of those that do is often
small (VonHoff et al., 1981; Sikic & Taber, 1981;
Sandbach et al., 1982). In vitro growth of breast
tumours is also limited in other culture systems
(Courtney & Mills, 1978). Small proportions of
clonogenic tumour cells of primary neoplasms or
deficient culture conditions are possible causes for
failure.
We investigated the effect on colony formation of
nutrients by modifying the culture conditions for
breast tumours. Since established tumour cells have
in common with tumour stem cells their tissue of
origin, we reasoned that a group of cell lines with a
spectrum of biologic properties similar to those of
primary tumours may serve as a primary screen to
identify the nutritional requirements of primary
tumours.
We have investigated this hypothesis by
identifying, in a systematic stepwise fashion, the
culture conditions for clonogenic growth of 4
selected breast tumour cell lines that differed in
growth kinetics, hormonal dependency and
tumourgenicity: MCF-7, MDA-231, MDA-435 and
MDA-468 (Table I). MCF-7 has functional
receptors for 17-fl-estradiol, hydrocortisone, insulin
and epidermal growth factor (Osborne & Lippman,
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1978), and these modifying agents were investigated
for hormone-dependent tumour cells. Conditioned
medium (CM) was investigated as a potential
source of mitogens and of growth-regulatory
autocrine factors for hormone independent tumour
cells (Todaro, 1980; Sirbasku, 1978).
Culture conditions so defined were then applied
to 105 primary breast tumours and their clonogenic
growth compared to that of 52 tumours cultured
under conventional conditions. The effects of
hormones and CM was further evaluated on 26
tumours cultured simultaneously under the two
conditions.
Materials and methods
Materials
Enriched McCoy's medium was prepared following
the guidelines indicated by Salmon and VonHoff,
and our ingredients were obtained from their
sources (Soehnlen, 1980). Ham's nutrient mixture
F12 (F12), Dulbecco's modified essential medium
(a-MEM) and Leibovitz's L-15 medium (L-15) were
purchased from Grand Island Biological Company,
Grand Island, NY. Bactoagar Difco was obtained
from American Scientific Products, Houston, TX;
agarose from FMC Corporation, Rockland, ME;
and methylcellulose, 400 Centipoises, from Fisher
Scientific, Houston, TX. Foetal bovine serum (FBS)
and horse serum (HS) were purchased from K.C.
Biological, Lenexa, KA; epidermal growth factor
and bovine insulin from Collaborative Research,
Waltham, MA; crystalline hydrocortisone, 17-f-
oestradiol and deoxyribonuclease from Sigma
Chemical Corporation, St. Louis, MO. Collagenase
Type III and elastase were obtained from
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Table I Characteristics of breast tumour cell lines
Plating efficiencyc
Oestrogen receptor in conventional in modified
content (fmmg' Doubling Tumourformation cultures cultures
Designation cytosol protein)a time (h)b in nude mice (%) (%)
MCF- 18.7 80 Yes <5 30
MDA-231 < 1.0 30 Yes 7 60
MDA-435 < 1.0 24 No <5 35
MDA-468 <1.0 40 Yes <5 15
'Determined by the dextran-coated charcoal method.
bEstimated by the dilution factor relative to time between subcultures when maintained as monolayer cultures in
Leibovitz's L-15 medium at 37°C.
cIn semisolid agar cultures.
Worthington Biochemical, Freehold, NJ,
deoxyribonuclease from Sigma Chemical Corp., St.
Louis, MO, and Trypsin-EDTA from Gibco,
Grand Island, NY.
Tumour cells
MCF-7 breast tumour cells were obtained from the
laboratory of Dr. H. Soule, Michigan Cancer
Foundation, Detroit, MI; and cell lines MDA-231,
MDA-435 and MDA-468 from Dr. R. Cailleau,
University of Texas M. D. Anderson Hospital. All
cell lines were derived from pleural effusions of
patients with stage IV breast carcinoma. Details of
origin and propagation of these established cells
have been described previously (Soule et al., 1973;
Cailleau & Reeves, 1975). They were maintained in
L-15, supplemented with 15% FBS and subcultured
weekly.
Primary tumour samples were obtained from 257
patients treated for advanced breast cancer in the
Departments of Surgery and of Medical Oncology
of the University of Texas M. D. Anderson
Hospital. Informed consent was obtained prior to
each sample collection.
Preparation ofCM
Cell lines MDA-231, MDA-435 and MDA-468
were adapted to growth under serum restriction
over a period of 6-8 weeks. Prior to collection of
supernatants, cells were exposed to 2% Trypsin-
EDTA for 6h. Supernatants of all three established
tumour cells were then combined at equal volumes,
filtered through a 20pm mesh, centrifuged at 400g
for 30 min and stored at -20°C.
Preparation ofsingle-cell suspensions
Established cells were detached from their
monolayer cultures with rubber policemen, and
single-cell suspensions were obtained by vigorous
pipetting.
Primary tumours were washed with calcium- and
magnesium-free Hanks' balanced salt solution
(CMF-HBSS), and fat and necrotic tissue was
trimmed. They were then sliced into 1 mm cubes,
and single cells were teased into suspension with 25-
gauge needles. Cell suspensions were then incubated
in a mixture of Worthington Type III collagenase,
deoxyribonuclease and elastase at the final
strengths of 0.7%, 0.6% and 0.005%, respectively,
at 37°C under low-speed magnetic stirring.
Effusions were centrifuged at 80g for 20 min, and
the cell pellets were resuspended in 5ml F12. The
cells were then treated in the same manner as solid
tumour cell suspensions with the exception that no
elastase was used. The enzyme mixture was renewed
after 4h, and the incubation continued for another
8h. At completion of the enzymatic dissociation
procedure, cells were washed in CMF-HBSS and
resuspended in F12. Cells and residual clumps were
counted in a haemocytometer; viability of cells was
determined by exclusion of trypan blue dye; and a
differential cell count was performed on a cytospin
preparation. Clumps were defined as aggregates of
more than 3 cells. Prior to culturing, all cell
suspensions were passed once through a 25-gauge
needle, and those suspensions with more than one
clump per 1,000 cells were serially passed through
18- to 25-gauge needles.
In vitro cultures ofestablished tumour cells
Double-layer semisolid cultures were used- as
described previously, with the exception that a-
MEM was used as culture medium and no DEAE-
dextran was added (Bradley et al., 1966;
Hamburger & Salmon, 1977a; Hug et al., 1983).
These conventional culture conditions were used in
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Briefly, equal volumes of 2X a-MEM containing
30% FBS and 1.0% agar were combined to form
the underlayers. 103-104 cells were suspended in
1/20th of the final plating volume of oa-MEM. Nine
aliquots of 2X oc-MEM with 30% FBS, one aliquot
of the cell suspension and 10 aliquots of 0.6% agar
were combined to prepare the upperlayers. Only
culture conditions of the underlayers were modified.
Hormones were supplemented from 100X stock
solutions, and 3.5X F12 was used for underlayers
of cultures that were modified by the addition of
CM. Triplicate cultures were obtained. They were
incubated in a fully humidified atmosphere of 5%
CO2 and 12% 02 in nitrogen at 37°C for 8 days.
Aggregates of >40 cells were then counted as
colonies with an Olympus IMT-inverted
microscope.
In vitro cultures ofprimary tumour cells
Five x 105 cells, 85% x-MEM, 15% FBS in 0.3%
agar were combined to form the upperlayers, and
70% F12, 20% CM, 10% HS and hormones in
0.5% agar constituted the underlayers. Hormones
and CM were deleted in the controls of the 26
tumours grown simultaneously under two
conditions. Triplicate cultures were obtained in all
instances. One plate of each primary tumour
culture was fixed with 0.5ml of 3% glutaraldehyde
and stored at 4°C; it served as references for
clump contamination. Cultures were incubated in a
fully humidified atmosphere of 5% CO2 and 12%
02 in nitrogen at 37°C for 14 days. An Olympus
IMT-inverted microscope was used to score the
cultures for colonies. Aggregates of >40 cells
(>75pm in diameter) and of uniform morphology
were considered to represent progenies of
clonogenic cells. The glutaraldehyde-fixed plates
were scored under the same criteria, and the
number of "colonies" enumerated was subtracted
from the scores of the cultured plates to obtain the
final score for the primary cultures.
Cytomorphologic criteria were used to identify the
colony-forming tumour cells.
Experimentalplanfollowed to define improvement of
cultures conditions
The sequence of experiments conducted to define
better culture conditions for breast tumour cells is
listed in Table II. Five major components were
investigated for substitutes in the following
sequence: culture medium, solidifying agent, serum,
conditioned medium, and defined growth factors.
At each step of investigation, the component that
best supported colony formation of most cell lines
(standard or substitute) was identified. The
standard compound was then replaced by this
superior compound in the culture condition that
served as control for the investigation of the next
culture component. Thus, with each step of the
investigation, the plating efficiency of the control
culture improved. All experiments were conducted
twice.
The culture conditions that resulted from this
series of experiments were subsequently applied to
the in vitro growth of 105 primary breast tumours.
Comparison of the cultures of these tumours were
then made with 52 tumours cultured earlier under
our regular conditions to determine whether the
factors required for the clonogenic growth of
established tumour cells could also modulate the
growth of primary tumour cells of the same tumour
type. Furthermore, the effect of hormones and CM
on colony formation was evaluated in a group of
26 primary tumours.
Results
A group of four breast tumour cell lines that
differed in their biologic properties was chosen to
simulate the heterogeneity of cell populations
contained in primary breast tumours. The
characteristics of these four cell lines are
summarized in Table I. MCF-7 was selected to
concord with the 30-40% clinical incidence of
hormonally-responsive breast tumours. These cells
have functional receptors for all 4 hormones
investigated (Osborne & Lippman, 1978). The
remaining 3 cell lines differed in their growth
kinetics and their ability to form tumours in nude
mice.
The results of the experiments conducted are
listed in Table II. They are expressed as ratio of
colony formation under modified and control
conditions. At each level of investigation, the
controls were adjusted to the findings of the
preceding set of experiments. Thereby, the plating
efficiency of the control cultures improved with
each step of investigation. Observations and
conclusions derived from these experiments are
listed in Table II. F12 and ax-MEM supported the
clonogenic growth of all cell lines just as well as
L-15, which had been used for their propagation,
and better than enriched McCoy's medium. F12
was subsequently used for culture medium of
underlayers and a-MEM for the culture medium of
upperlayers. Agarose was not a better solidifying
agent, and agar was therefore used for subsequent
cultures. HS supported the clonogenic growth of
breast tumour cells better than FBS and was
substituted for FBS of the underlayers. The growth-
stimulatory effects of CM were minimal. However,
CM was used for subsequent cultures, since it may
support the growth of primary tumour cells more
than the growth of the cells from which it was210 V. HUG et al.
Table II Sequence, results and observations of experiments conducted on established breast tumour cells to improve
culture conditions for primary tumour cells
Results ofculture modifications
CFa in Modified Conditions
CF in Control Conditions
Sequence ofexperiments MCF-7 MDA-231 MDA-468 MDA-435 Conclusions and comments
Step I
Effects of alternate nutrient
mixtures compared to enriched
McCoy's medium:
1:1 mixture of Ham's F12 and
Dulbecco's a-MEM nutrient mixtures:
Isocove's Modified Dulbecco's MEM:
Leibovitz's L15:
1.9
1.9
2.0
3.0
2.5
3.2
3.1
3.1
3.4
4.8
6.7
5.3
All alternate media were superior
to enriched McCoy's medium.
F-12/D was selected for underlayers
and a-MEM for upperlayers of
subsequent control conditions.
Step 2
Effects of alternate solidifying
agents compared to agar:
Agarose:
Step 3
Effects of alternate sera compared
to foetal bovine serum:
Horse serum (HS):
Swine serum:
Step 4
Effect of additional conditioned
medium (CM):
Step 5
Effects of additional growth
factor supplements:
Epidermal growth factor (EGF):
Insulin (I):
17-,B-Oestradiol (0):
Hydrocortisone (HC):
ND 0.8 4.5 0.2
Agar was maintained for
subsequent control conditions.
HS ranked best for all four cell
lines. Effective concentrations
1.4 1.8 1.3 2.4 ranged from 10-30%. FCS in the
ND ND 0.3 0.5 underlayers was replaced by
10% HS for subsequent control
conditions.
CM was prepared as described in
1.3 1.1 1.6 1.1 text and added to the underlayers
of the cultures at a concentration
of 20%.
1.6
1.7
1.6
1.7
1.3
1.3
1.4
1.2
1.0
1.4
1.4
1.7
1.2
1.2
1.4
1.4
See Figure 1 for dose-responses.
EGF was used at 50ngml-1, I at
10ugml-l,O at 5 x 10-7M and HC
at 25pgml- I for subsequent cultures.
aCF =Colony formation
derived. CM improved colony formation beyond
that of defined hormones in 6/16 primary tumours.
The growth-stimulatory effects of insulin,
hydrocortisone, 17-f1-oestradiol and epidermal
growth factor are shown in Figure 1. The ratio of
colonies formed under hormone-enriched and
hormone-depleted conditions was used to determine
the effects that resulted from the addition to the
cultures of graded concentrations of these
hormones. Comparison of the effect of all 4
hormones combined at the concentrations used for
subsequent cultures with that of increasing
concentrations of HS is illustrated in Figure 2.
While the combination of hormones enhanced
colony formation of all 4 cell lines, the
concentration of HS necessary to improve the
plating efficiency of line MDA-468 inhibited the
growth of the remaining cell lines.
The culture conditions derived from this series of
experiments are summarized in Table III. Their use
improved the plating efficiencies of the established
tumour cells by a factor greater than 3 (Table I).
These conditions were then applied to the cultures
of 105 primary human breast tumours. Most cellsIMPROVED CULTURE CONDITIONS FOR HUMAN BREAST TUMOURS
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Figure 1 Dose-response curves in semisolid cultures of hormones and growth factors used for investigation.
The cell lines are indicated with the following symbols: MCF-7 ( ); MDA-231 (---); MDA-435 (---)
and MDA-468 (----). Data points represent mean values of 6-9 observations from 3 separate experiments.
Factors improved the plating efficiency significantly were: epidermal growth factor for MCF-7 and MDA-435;
insulin for all four cell lines; 17-fi-oestradiol for MCF-7, MDA-435 and MDA-468; and hydrocortisone for
MCF-7, MDA-231 and MDA-435.
Table Ill Modified culture conditions for breast tumours
Composition of
underlayers:
Composition of
upperlayers:
Hormonal
supplements:
plus EGF, Insulin,
17-fi-Oestradiol,
Hydrocortisone
% Horse serum in bottom layer
Figure 2 Investigation of substitutes for the
conventional 15% FBS in the underlayers. The effects
on colony formation of increasing concentrations of
HS were compared with those of 10%HS plus
50 ngml -1 epidermal growth factor, I0pgml - I insulin,
2.5 ugml-' hydrocortisone and S x 0-'M 17-fl-
oestradiol.
B.J.C.- D
70% F12
20% CM
10% HS
in 0.5% agar
85% a-MEM
15% FBS
5 x 10' tumour cells
in 0.3% agar
5 x 10-7M 17-,B-oestradiol
2.5jugml1 hydrocortisone
50ngml-epidermal growth factor
10,ugml bovine insulin
obtained after dissociation of these tumours were
viable (median 91%, range 42-100%). Over half of
the cells of most specimens were tumour cells
(median 56%, range 10-99%). The median number
of colonies formed was 84, and 6% of these
represented contaminating clumps (range 0-80%),
as estimated by the glutaraldehyde-fixed plates.
Variation in colon formation of replicate cultures
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Table IV Comparison of clonogenic breast tumour growth, before and after modification of
culture conditions
Conditions derived
Conventional from cell line
Characteristics conditions experiments
No. of specimens 52 105
Percent tumours that
formed .5 colonies 73a 93a
Percent tumours that
formed >30 colonies 38b 83b
Plating efficiency
median 0.0032 0.0158
range <0.0002-0.1118 <0.002-0.2252
a,bDifferences significant at levels 0.001 by Fisher's exact test.
was less than 20% for tumours that formed more
than 20 colonies. The observed growth of these 105
tumours is summarized in Table IV and is
compared with that of 52 tumours that had been
cultured previously under conventional conditions.
The culture modifications resulted in a growth
improvement factor of 5. Correlations of these in
vitro cultures with oestrogen receptors of the
tumours and with patient survival have been
reported elsewhere (Hug et al., 1984b). In addition
to these 105 tumours, 26 tumours were
simultaneously cultured under presence and absence
of hormones and CM. The characteristics of their
single cell suspension were similar to those of the
previously cultured tumours. The hormone and
CM-containing conditions improved the medium
plating efficiency of these tumours four-fold.
Sensitivity determinations were performed on all
cultures for a variety of anticancer drugs, and the
results of these have been reported separately (Hug
et al., 1984a, & submitted). By applying the
commonly used criterion of 30 or more colonies for
a workable assay, twice as many tests became
evaluable as a consequence of these culture
modifications (Table IV).
Discussion
Cultures of primary tumours have wide areas of
application, both in the field of basic research and
of clinical science. Because of the genetic instability
of tumour cells, many different stem cell
populations compose and maintain individual
tumours. Clonogenic tumour cells are the in vitro
counterpart of these stem cells. However, only a
fraction of all tumours form colonies in semisolid
cultures, and the number of colonies of those that
do is generally very small. A low portion of tumour
stem cells, or deficiencies of their exogenous growth
support can explain these observations. Culture
deficiencies can be qualitative and quantitative,
since growth factors are generally mediated through
receptors that are only expressed during certain
phases of the cell cycle.
Established cell lines have origin and self-renewal
ability in common with tumour stem cells. We
reasoned that if culture deficiencies are a causative
factor for the limited in vitro growth of tumour
stem cells, these conditions could be improved
using established cell lines as a tool to identify the
nutrient requirements of primary tumours. To this
end, we selected a group of breast tumour cell lines
with diverse growth characteristics to cover the
range of biologic behaviour of the primary tumour
type. We then defined type and effective dose-range
of nutrients required for their clonogenic growth by
testing a series of defined and non-defined growth
factors.
Our findings indicate that clonogenic tumour
growth can be influenced by exogenous nutritional
support, and that therefore a low proportion of
stem cells is not the only cause for the observed low
plating efficiency ofprimary tumours.
Certainly, our culture modifications led to an
only modest improvement of the clonogenic growth
of both established and primary tumour cells.
However, we did not intend to optimize culture
conditions for primary breast tumours. We merely
tested the feasibility and validity of an alternate
approach to improve culture conditions for primary
tumours using breast tumours as an example. To
assess the biologic relevance of these in vitro
recovered clonogens, we also determined their
inherent sensitivities to anticancer drugs. A
concordance of in vivo and in vitro findings of 70%
(Hug et al., 1984a) indicates that, in fact, a
meaningful relationship does exist between stem
cells and clonogenic cells of primary tumours.
We conclude that deficient culture conditions areIMPROVED CULTURE CONDITIONS FOR HUMAN BREAST TUMOURS 213
a contributary cause of the low plating efficiency of
primary tumours and that these deficiencies can in
part be identified by defining the growth
requirements of established tumour cell lines of the
same tumour type.
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